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Background: Several epidemiological studies have observed an increased risk of type 2 diabetes mellitus (T2DM)
among subjects with a higher consumption of red and processed meat. Heme iron intake has been directly
associated with a higher risk of T2DM in healthy adult Chinese and U.S populations. The objective of the present
study was to evaluate the association between heme iron intake and the incidence of T2DM in a Mediterranean
population at high cardiovascular risk.
Methods: We assessed a subset of participants in the PREDIMED trial as an observational cohort, followed up for a
maximum of eight years. We initially included 1073 non-diabetic subjects (57.1% women) aged 67.3 ± 6.0 years, at
high cardiovascular risk. Diet was assessed at the study baseline using a validated, semi-quantitative food frequency
questionnaire.
Results: During the follow-up period 131 diabetics were newly diagnosed. The risk of developing T2DM was assessed
using baseline heme iron intake and proportional hazard models, first unadjusted, then adjusted for energy, and finally
adjusted for dietary, anthropometric, socio-demographic and lifestyle variables. Significant direct associations with the
incidence of T2DM were found for heme iron (Hazard Ratio [HR] 1.30, 95% confidence interval [CI], 1.02 to 1.66).
Secondarily, we have also observed that coffee (HR:0.93, 95% CI, 0.89 to 0.98) and alcoholic beverages (HR: 1.02, 95% CI,
1.01 to 1.04) were also found to reduce and increase the risk of T2DM, respectively.
Conclusion: High dietary intake of heme iron was associated with an increased risk of developing T2DM in a
Mediterranean population at high cardiovascular risk.
Trial registration: Identifier: ISRCTN35739639.Background
In recent years the prevalence of T2DM has increased
worldwide. It has been estimated that the number of
people aged 20 to 79 years affected by T2DM will in-
crease from 285 million in 2010 (6.4%) to 439 million in
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distribution, and reproduction in any mediumDiet is one of the components of lifestyle that has
most been studied in the prevention of T2DM. A recent
meta-analysis reported that red meat, and particularly
processed meat [2], is associated with a greater risk of
T2DM incidence. In recent years, some studies in healthy
adult Chinese [3,4] and U.S populations [5-7] suggest that
the component of meat responsible for this association
could be the intake of total iron [3] or heme iron [4-7].
The deregulation of iron homeostasis has been impli-
cated in the origin of such pathologies as cancer, Alzhei-
mer’s disease, cardiovascular disease and T2DM, among
others [8]. Although the exact mechanism by which ironCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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being a pro-oxidant element, it strengthens the forma-
tion of hydroxyl radicals [9], thus favouring situations of
oxidative stress and contributing to insulin resistance or
long-term pancreatic failure [9].
The association between heme iron intake and in-
creased risk of T2DM has been studied in the general
population, but not in individuals at high cardiovascular
risk. Therefore, the objective of the present study was to
evaluate the effect of heme iron intake on the incidence
of T2DM in a nondiabetic Mediterranean population at
high cardiovascular risk.
Methods
The study design was an observational cohort analysis of
a subset of non-diabetic participants in the PREDIMED
trial [10], who were followed up between 1 and 8 years
(median 4.85 ± 1.28 years). PREDIMED is a large multi-
centre, randomized, controlled trial that attempts to test
the efficacy of the Mediterranean diet (MeDiet) in the
primary prevention of cardiovascular disease. Two trad-
itional Mediterranean diets were evaluated – one enriched
with extra virgin olive oil and the other with mixed nuts –
along with a control low-fat diet normally recommended
for cardiovascular disease prevention in a high-risk popu-
lation. Full details of the PREDIMED trial (http://www.
controlled-trials.com/ISRCTN35739639) have been pub-
lished elsewhere [10].
Study participants
The present study was conducted on 1 073 subjects: 460
men aged 55 to 80 years, and 613 women aged 60 to
80 years from two PREDIMED trial centers (Reus and
Pamplona). The subjects included were non-diabetics and
had three or more of the following cardiovascular risk fac-
tors: current smoker (>1 cigarette/day for the past month),
high blood pressure (systolic ≥ 140 mmHg or diastolic ≥
90 mmHg or taking blood pressure medication), LDL chol-
esterol ≥ 169 mg/dl or lipid-lowering treatments, HDL
cholesterol ≤ 40 mg/dL in men or ≤ 50 mg/dL in women;
body mass index (BMI) ≥ 25 kg/m2; and family history of
premature coronary disease (≤ 55 years in men and ≤
60 years in women). Exclusion criteria were a previous his-
tory of cardiovascular disease (coronary heart disease,
stroke or peripheral arterial disease); any severe chronic ill-
ness; alcohol or drug abuse; BMI > 40 kg/m2; more than a
5% loss in body weight in the last year; and a history of al-
lergy to nuts [10]. The Clinical Research Ethics Committee
of the Hospital Sant Joan de Reus approved the study
protocol and all participants provided written informed
consent.
During the follow-up a total of 131 incident cases of
T2DM were diagnosed using the American Diabetes As-
sociation criteria [11] (fasting blood glucose ≥ 7.0 mmol/L or blood glucose ≥ 11.1 mmol/L after an oral dose of
75 g glucose, measured annually). A second test with the
same criteria was required to confirm the diagnosis. In-
cident T2DM cases were confirmed by the PREDIMED
study’s Clinical Events Committee.
Measurements
Dietary intake was determined at baseline using a validated
137-item, semi-quantitative food frequency questionnaire
[12]. For the present analysis, food was grouped according
to its nutritional composition. Finally, consumption of the
following food groups was calculated: dairy; meat, fish and
eggs; cereals, legumes and nuts; vegetables; fruits; oils and
fats; candies and sweetened beverages; alcoholic beverages;
tea and coffee. Total energy and nutrient intake were calcu-
lated on the basis of Spanish food composition tables [13].
Sociodemographic, anthropometric (weight, height, waist
circumference) and biochemical data were also recorded at
baseline and on each annual visit to identify health prob-
lems such as obesity (BMI ≥ 30 kg/m2), hypercholesterol-
emia (total cholesterol ≥ 240 mg/dl), hypertriglyceridemia
(triglycerides ≥ 200 mg/dl) and hypertension (systolic blood
pressure ≥ 140 mmHg and/or diastolic blood pressure ≥
90 mmHg). The last three cardiovascular risk factors were
defined according to the Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Chol-
esterol in Adults (Adult Treatment Panel III) [14].
The participants were divided into three grups: 0 –
control group; 1 – Mediterranean Diet supplemented with
olive oil; and 2 – Mediterranean Diet supplemented with
nuts. Subjects were assessed as smokers or non-smokers.
Education was recoded into two categories: high-medium
and low. Finally, we created a categorical variable of heme
iron intake: 1 – low (< 3.173 mg), 2 – medium (3.173–
4.130 mg) and 3 – high (> 4.130 mg) consumers.
Statistical analysis
The data are presented as a percentage or average ± stand-
ard deviation. Statistical testing included chi-square tests
for qualitative variables and the t-Test for quantitative data.
First, we studied whether there was a linear relation-
ship between heme iron intake and T2DM. Because the
association between heme iron intake and T2DM was
linear and at the border of significance (P = 0.05), we de-
cided to analyze the association in the total population
with several proportional hazard models. The first model
used raw data with unadjusted heme iron intake. The
second model used data adjusted for energy intake. And
the final model was adjusted for dietary, anthropometric,
socio-demographic and lifestyle variables: for example,
age, sex, waist circumference, smoking, education level
and intervention group. Some components of foods that
can interfere with heme iron absorption were also adjusted
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cereals, legumes and nuts [vegetable protein], calcium, al-
cohol beverages, tea and coffee (the last two representing
the consumption of polyphenols). Fruit was included as an
adjustment variable because consumption was significantly
higher in the group of non-diabetics. The variable “time to
onset of T2DM” was measured in days. No interactions
were found between sex and age.
Because the association between heme iron intake and
T2DM was linear and at the border of significance, we
decided to analyze the association for each tertile of
heme iron intake, using the same adjustment variables
and the last proportional hazard model.
Significance was set at P < 0.05. The data were ana-
lysed using version 20.0 of the SPSS statistical package
for Windows.
Results
A total of 12.2% of the initial sample developed T2DM
with a median follow-up of 4.8 ± 1.3 years. Table 1 shows
the general baseline characteristics of non-incident and in-
cident diabetics. At baseline, weight, BMI, waist circum-
ference and smoking prevalence were significantly higher
in incident than in non-incident T2DM subjects.
Table 2 shows the average consumption of the differ-
ent food groups, the total energy intake and the con-
sumption of main nutrients at baseline in non-incident
and incident diabetics in total subjects and subjects clas-
sified according to tertiles of heme intake. The group of
incident T2DM subjects consumed less fruit (P = 0.010)
and coffee (P = 0.001), and more heme iron (P = 0.036)
than the non-incident group in the total sample but not by
tertiles. Only in the second (P = 0.040) and third (P = 0.029)Table 1 Baseline general characteristics of participants in
incident and non-incident diabetics






n = 942 (87.8%) n = 131 (12.2%)
Age (years) 67.3 ± 6.0 66.3 ± 5.7 0.073
Weight (kilograms) 75.3 ± 10.8 79.2 ± 10.6 < 0.001
IMC (kg/m2) 29.4 ± 3.1 30.4 ± 3.1 0.001
Waist circumference (cm) 97.2 ± 9.9 101.8 ± 9.3 < 0.001
Women (%) 57.7 52.7 0.271
Obesity (%) 41.5 48.1 0.153
Hypercholesterolemia (%) 35.8 35.7 0.992
Hypertriglyceridemia (%) 16.3 23.8 0.239
Hypertension (%) 65.6 62.8 0.719
Smoking (%) 16.3 25.2 0.012
Medium-high education (%) 26.9 27.9 0.807
Results expressed as mean ± standard deviation or percentages.tertiles was coffee consumption significantly higher in
non-incident than incident diabetics.
To evaluate the association between heme iron intake
and various components of the diet with the risk of T2DM,
proportional hazard models were applied (Table 3). The
first model used raw data with unadjusted heme iron intake
(HR = 1.13, 95% CI, 0.99 to 1.30; p = 0.075). The second
model used data adjusted for energy intake (HR = 1.20, 95%
CI, 1.02 to 1.42; p = 0.029). And the final model was ad-
justed for dietary, anthropometric, socio-demographic and
lifestyle variables and showed that greater heme iron intake
(HR = 1.30, 95% CI, 1.02 to 1.66; p = 0.037) was associated
with an increased risk of T2DM onset. Although it was not
our principal aim, we also observed an association between
others components of the diet and the risk of T2DM. Thus,
the consumption of alcohol beverages was associated with
an increased risk of T2DM (HR= 1.02, 95% CI, 1.01 to
1.04), while coffee was associated with better protection
against T2DM incidence (HR = 0.93, 95% CI, 0.89 to 0.98).
Furthermore, when we constructed the last propor-
tional hazard model, by dividing subjects into tertiles of
heme iron intake, we observed no significant association
in either the first tertile of heme iron intake (HR = 1.58,
95% CI, 0.52 to 4.78; P = 0.175) or the second (HR = 1.59,
95% CI, 0.50 to 5.06; P = 0.013), but there was a significant
association in the third tertile and T2DM (HR = 1.57, 95%
CI, 1.09 to 2.27; P = 0.003).
Discussion
Several epidemiological studies have linked excess iron de-
posits and risk of T2DM [3,4,15]. However, few studies have
analysed the association between heme iron intake and
T2DM [3-7,16]. The present prospective study shows that
higher amounts of dietary heme iron are associated with a
higher risk of T2DM. This is the first time that this associ-
ation has been assessed in a large elderly Mediterranean
population at high cardiovascular risk.
This association has been evaluated in four long-term
prospective studies [5-7,16] and two cross-sectional studies
[3,4]. However, most of them were conducted in healthy
cohorts of U.S adults (Professionals Follow-up Study,
Women’s Health Study, Nurse’s Health Study and MESA),
and showed that the intake of heme iron is associated with
an increase in the risk of T2DM [5-7]. Only one study
found no association [16]. In the Health Professionals
Follow-up Study cohort, heme iron derived from red meat
consumption, but not total iron intake, was positively asso-
ciated with risk of T2DM [5]. In the Iowa Women’s Health
Study cohort of postmenopausal women, a high intake of
heme iron and/or iron supplements was associated with in-
creased incidence of T2DM, especially in subjects who
consumed alcohol [7]. Lastly, in the Nurses Health Study,
the association between T2DM incidence and iron intake
was demonstrated only for heme iron intake, but not for
Table 2 Baseline food, energy and nutrient consumption in incident cases of diabetes and controls







NON INCIDENT INCIDENT DIABETICS NON INCIDENT INCIDENT DIABETICS
n = 942 (87.8%) n = 131 (12.2%) n = 324 (90.8%) n = 33 (9.2%) n = 310 (86.6%) n = 48 (13.4%) n = 358 (86.0%) n = 50 (14.0%)
Heme iron (mg/day) 3.7 ± 1.19 3.9 ± 1.3 0.036 2.5 ± 0.3 2.6 ± 0,4 3.6 ± 0.3 3.7 ± 0.3 5.1 ± 0.9 5.1 ± 1.2
Non-heme iron (mg/day) 12.0 ± 3.23 11.8 ± 3.4 0.538 11.1 ± 3.0 10.3 ± 2.7 11.9 ± 2.8 12.0 ± 3.6 13.2 ± 3.5 12.8 ± 3.4
Iron (mg/day) 15.7 ± 3.80 15.8 ± 4.0 0.886 13.6 ± 3.1 12.8 ± 2.8 15.5 ± 2.9 15.7 ± 3.6 18.2 ± 3.9 17.9 ± 3.8
Vitamin C (mg/day) 170.5 ± 69.56 165.0 ± 58.1 0.394 153.5 ± 62.9 140.6 ± 64.9 175.2 ± 68.9 161.6 ± 53.2 183.6 ± 73.4 184.5 ± 52.0
Calcium (mg/day) 978.6 ± 328.73 963.5 ± 368.6 0.628 853.7 ± 289.7 820.4 ± 246.6 997.5 ± 309.9 927.6 ± 313.9 1091.0 ± 341.7 1092.4 ± 440.6
Fiber (g/day) 23.0 ± 6.74 22.2 ± 6.7 0.189 21.9 ± 6.6 20.5 ± 7.3 22.8 ± 5.9 21.9 ± 6.1 24.4 ± 7.4 23.6 ± 6.8
Carbohydrates (g/day) 241.1 ± 72.28 228.3 ± 79.8 0.062 222.5 ± 70.5 188.2 ± 47.9 238.2 ± 63.5 233.3 ± 79.8 263.4 ± 76.5 250.0 ± 87.7
Protein (g/day) 90.1 ± 19.76 90.8 ± 19.5 0.687 75.0 ± 14.0 73.3 ± 9.9 89.2 ± 12.4 89.77 ± 13.6 106.9 ± 17.7 103.4 ± 20.1
Total fat (g/day) 102.7 ± 27.02 104.5 ± 28.1 0.482 89.5 ± 22.3 89.0 ± 26.4 102.3 ± 22.1 103.8 ± 27.0 117.4 ± 28.7 115.4 ± 25.8
Total energy (Kcal/day) 2 328.5 ± 553.55 2 322.9 ± 607.0 0.916 2059.3 ± 484.7 1912 ± 362.9 2305.5 ± 446.8 2344.6 ± 610.3 2634.8 ± 76.5 2573.4 ± 596.9
Dairy (g/day) 369.6 ± 212.0 351.1 ± 233.2 0.357 342.5 ± 201.8 344.2 ± 184.1 382.5 ± 209.8 335.1 ± 200.4 385.1 ± 222.4 371.1 ± 288.1
Meat, fish and eggs (g/day) 231.4 ± 67.1 237.7 ± 60.4 0.303 177.2 ± 41.1 181.4 ± 37.7 229.1 ± 41.9 238.0 ± 40.3 290.6 ± 60.3 237.7 ± 60.4
Cereals, legumes & nuts (g/day) 196.5 ± 91.2 196.1 ± 101.0 0.961 185.3 ± 90.7 164.9 ± 60.2 188.6 ± 82.2 199.5 ± 109.1 216.4 ± 97.1 213.5 ± 110.9
Vegetables (g/day) 279.6 ± 108.8 276.3 ± 105.1 0.741 254.3 ± 96.6 243.6 ±105.8 277.9 ± 103.5 250.0 ± 97.3 308.2 ± 119.1 323.2 ± 96.3
Fruits (g/day) 352.9 ± 181.3 315.4 ± 150.8 0.010 328.8 ± 170.6 278.8 ± 177.2 373.1 ± 186.1 329.5 ± 135.8 357.8 ± 185.0 326.0 ± 144.8
Oils & fats (g/day) 57.9 ± 22.0 60.5 ± 25.0 0.220 53.0 ± 19.9 52.5 ± 19.3 57.5 ± 21.0 62.4 ± 29.9 63.6 ± 23.8 63.9 ± 22.4
Alcoholic beverages (cc/day) 128.5 ± 190.9 17.0 ± 287.4 0.087 106.5 ± 185.2 91.1 ± 151.2 132.1 ± 210.3 174.4 ± 221.3 147.9 ± 173.7 225.7 ± 387.2
Coffee (cc/day) 31.5 ± 47.5 20.5 ± 32.9 0.001 27.2 ± 46.1 16.0 ± 33.4 31.4 ± 43.8 20.6 ± 31.5 36.0 ± 52.2 23.4 ± 34.3
Tea (cc/day) 5.3 ± 23,1 4.5 ± 13.2 0.720 4.6 ± 25.6 3.0 ± 10.9 5.8 ± 24.3 5.1 ± 14.1 5.4 ± 23.1 4.9 ± 13.2




















Table 3 Cox regression evaluating the association between heme iron intake and the risk of new onset diabetes
VARIABLES P1 HAZARD RATIO 95% Confidence interval for hazard ratio
Lower Higher
Model 1: Heme iron 0.075 1.13 0.99 1.30
Model 2: Heme iron + 0.029 1.20 1.02 1.42
Energy 0.210 0.98 0.94 1.01
Model 3: Heme iron + 0.037 1.30 1.02 1.66
Energy + 0.113 0.95 0.88 1.01
Animal protein + 0.155 0.97 0.93 1.01
Vegetable protein + 0.320 1.02 0.99 1.05
Fruit + 0.339 0.99 0.98 1.01
Alcoholic beverages + 0.005 1.02 1.01 1.04
Coffee + 0.005 0.93 0.89 0.98
Tea + 0.665 0.98 0.89 1.08
Calcium 0.747 1.01 0.95 1.08
Last model adjusted also for age (years), gender, waist circumference (cm) (P < 0.001; Exp(B) = 1.05), education level (medium-high, low), intervention group
(control, olive oil and nuts) and smoking.
Heme iron (mg/day), energy intake (100 kcal/day), animal protein [meat, fish and eggs] (10 g/day), vegetables protein [cereals, legumes and nuts] (10 g/day), fruit
(10 g/day), alcoholic beverages (20 cc/day), coffee (10 cc/day), tea (10 cc/day), calcium (100 mg/day).
1P-value for hazard ratio.
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The association between total iron [3] or heme iron intake
[4] and prevalent T2DM was also cross-sectionally ob-
served in healthy adult Chinese populations. Finally, a re-
cent meta-analysis and systematic review suggest that
increased heme iron intake is associated with higher risk of
T2DM [17]. The association between heme iron intake
before pregnancy and/or during the early period of
pregnancy and gestational diabetes was also recently re-
ported in the Nurses Health Study II [18] and the U.S.
Omega cohort [19].
These findings have been reinforced by the fact that
several studies have found an association between ele-
vated levels of iron and the risk of T2DM [3,4,15]. Re-
cently, a study on the Potsdam EPIC cohort found that
high ferritin levels – above 110 ng/mL in females and
280 ng/mL in males – were associated with an increased
risk of T2DM [15].
Blood donations and phlebotomy have also been ob-
served to have a positive effect on insulin sensitivity and
risk of T2DM because they reduce body iron levels.
Fernandez-Real et al. observed a decrease in body iron
levels and improved insulin sensitivity in healthy subjects
who made frequent blood donations (at least 2 in the pre-
vious 5 years) [20]. They also found that the number of
donations was positively correlated with insulin sensitivity.
The same authors had previously observed that both insu-
lin secretion and sensitivity, and glycosylated hemoglobin
levels improved in diabetic patients undergoing phlebot-
omy [21]. These results appear to show that iron reduc-
tion has a beneficial effect on the occurrence of T2DMand controls the parameters associated with T2DM. Inter-
ventional studies should be carried out to determine
whether reducing the heme iron intake diminishes the risk
of healthy subjects developing T2DM and improves con-
trol and management of patients with T2DM.
Although the exact mechanism by which iron induces
T2DM and other diseases is unclear [8], there is increas-
ing evidence to suggest that iron status has a considerable
influence on the oxidative damage suffered by biomole-
cules such as DNA [22]. It has been speculated that this
phenomenon can affect the physiopathology of such key
events in the onset of T2DM as insulin resistance or defi-
ciency [9]. For example, storage of iron in pancreatic β
cells could affect β cell secretion [23], inducing apoptosis
mediated by oxidative stress [24].
The bioavailability of heme iron is determined by diet
and is probably one of the important factors that ex-
plains why heme iron is the component of the diet that
has consistently been associated with a risk of T2DM by
our study and others. For this reason, the following factors
were included in the proportional hazard models: meat,
fish and eggs [animal protein]; cereals, legumes and nuts
[vegetable protein]; alcoholic beverages; tea and coffee and
calcium. This last factor, in conjunction with polyphenols
[25], inhibits heme iron absorption [26]. The effects of
polyphenols were regarded as being indirectly due to the
consumption of tea and coffee, which are rich in phenolic
compounds. Alcohol beverages were included because it
has been suggested that acute or chronic exposure to alco-
hol can suppress hepcidin expression in the liver, which
increases the intestinal transport of iron into plasma [27].
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factor that influences heme iron absorption [28], was esti-
mated from the consumption of cereals, legumes and
nuts. Another important factor involved in heme iron ab-
sorption is animal protein [28]. In the proportional hazard
models this is presented as “meats, fish and eggs [animal
protein]”. Although the variable “meats, fish and eggs [ani-
mal protein]” shows collinearity with “heme iron”, we de-
cided to include both in the proportional hazard models
because they assess different aspects. “Heme iron” is asso-
ciated with the quantity of iron in the diet and “meats and
fish [animal protein]” with facilitating iron absorption. In
addition, “meats, fish and eggs [animal protein]” improved
the β coefficient of the primary variable, “heme iron”, and
the general model, both of which support the inclusion of
these variables.
The results of our study are in agreement with those
of other epidemiological studies [3-7]: a high intake of
heme iron seems to be associated with an increased risk
of T2DM, also in a Mediterranean population at high
cardiovascular risk. This relationship was particularly evi-
dent in our study at high doses of heme iron intake. Al-
though it is not fully understood why results vary according
to the form of iron intake, heme iron is more bioavailable
because its absorption is independent of body iron status
and elevated heme iron intake has been associated with
high levels of serum ferritin [29], which in turn is related to
greater risk of T2DM [4].
On the final proportional hazard model applied, we also
observed a positive association between the consumption
of alcohol beverages and an increased risk of T2DM. On
the other hand, coffee consumption was associated with a
reduced risk, as has previously been observed in other
studies [30]. The negative relationship between coffee con-
sumption and the risk of T2DM could also be explained
by the positive relationship between caffeine and insulin
sensitivity, and between decaffeinated coffee and β cell
function [31]. Polyphenols, including coffee and tea poly-
phenols, seem to inhibit the uptake of intestinal hemo iron
[25], thus reducing its adverse effects. In the case of alco-
hol beverages, the presence of alcohol seems to have a det-
rimental effect on the metabolism of iron. In American
postmenopausal women aged 55 to 69 years, an associ-
ation was observed between higher heme iron or supple-
mented iron intake and greater risk of developing T2DM,
especially in those who also consumed alcohol [7]. High
or moderate consumption of alcohol was associated with
a significant increase in the risk of iron overload [32]. In
this regard, Whitfeld et al. observed that ferritin and iron
serum were increased by alcohol consumption [33], and
this, in turn, was associated with a risk of TDM2 [34].
Because of the observational nature of our study, we
cannot completely establish a cause-effect relationship be-
tween heme iron intake and the risk of developing T2DM.However, the covariates in the statistical models minimize
the major sources of confounding. One of the strengths of
the study was that the diagnosis of T2DM was not self-
reported and was verified by a second analytical test, thus
making the identification of new incident cases more reli-
able and accurate. However, some participants did not
undergo an OGTT, so T2DM could only be diagnosed by
fasting blood sugar ≥ 7.0 mmol/L confirmed by a second
test. This might have falsely lowered overall incidence
rates. Finally, the dietetic variables used in the analysis
were obtained from a semiquantitative food frequency
questionnaire that had been validated in the same popula-
tion so that the possibility of error was reduced [12].Conclusion
In conclusion, the results of the present study show that
an elevated heme iron intake was associated with a sig-
nificant increase in the risk of T2DM incidence in a
Mediterranean population at high cardiovascular risk.
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